Member Info for ThinShins

ChatGPT shortlists the below 3 labs:

SYNLAB UK & Ireland – fits perfectly (large, “leading”, runs NHS labs, capable of validation).

The Doctors Laboratory (TDL) – another strong fit; widely respected, works with NHS, major biomarker expertise.

Randox Laboratories – known for biomarker and early detection R&D, though less of a direct NHS “service provider” day-to-day.

Https://frontierblaze.com/bill-behnke/

Hi TT,

Im not sure to how big of a player Omni is, there really isn't much info out there, im not sure if or how this ties up with omni but the Cizzle Bio investor site shows the below:

Clinical Validation at Top U.S. Cancer Centers (all currenlty showing as "validating")

Moffit Cancer Center, Tampa, FL

Mays Cancer Center, San Antonio, TX

hoag. Newport Beach, CA

UCLA, Los Angeles, CA

Duke Health, Durham, NC

Wellvana / Methodist Health Care

Georgetown Lombardi Comprehensive Cancer Center, Washington, DC

https://invest.cizzlebio.com/

Thanks LB

Hi lovelyboy,

Could you kindly share anything if you joined the webinar?

If anyone was wondering where I got the quote from: https://invest.cizzlebio.com/

If you scroll all the way to bottom there is a section to ask questions and seems like you get a direct response from BB.

Probably best that not everybody bombards it with questions as its likely then we would get no response, maybe somebody more knowledgeable can ask some important questions.

I'm encouraged after noticing the list of labs Ciz Bio is getting the test validated in.

Even though we aren't being informed regularly which isn't great at least there are signs of progression, I'd rather the Ciz teams focus on getting a solid launch than keeping us updated with every minute detail.

Also I quote Bill from 10 days ago "We are launching our test in the very near future."

Hi Green,

Interestingly lower down it shows Clinical Validation at Top U.S. Cancer Centers:

Moffit Cancer Center, Tampa, FL

Mays Cancer Center, San Antonio, TX

hoag. Newport Beach, CA

UCLA, Los Angeles, CA

Duke Health, Durham, NC

Wellvana / Methodist Health Care

Georgetown Lombardi Comprehensive Cancer Center, Washington, DC

I was signed up for the original webinar and haven't received anything informing its been rescheduled, checked my junk folder too.

As Ciz plc has no stake in the gastric test I dont believe its relevant, it wouldnt make sense for Ciz plc to send out RNS for this news when its not our test.

I think it may just be regurgitated in a different wording as ciz bio have recently been pushing developments which were already previously shared such as CEOCFO Magazine Interview, Jennifer Hinkels study showing saving on medicare with adoption of CIZ1B roll out and also the Cayman Island news. Previous developments and news probably being pushed out as part of the crowdfunding campaign.

Linkedin Post:

Cizzle Bio has officially launched its lung and gastric cancer blood tests in the Cayman Islands.

This marks our first international rollout and a key milestone in bringing early cancer detection to real-world clinical settings.

Through our agreement with Doctors Hospital, patients in the Caribbean will now have access to our CIZ1B and DEX-G2 biomarker tests.

Backed by decades of research and protected by exclusive rights, our biomarker-based tests are designed to detect cancer earlier through a standard blood draw.

With momentum building and U.S. clinical launch on the horizon, this is a critical moment for investors to get involved.

Hi Tech,

"Due to an unanticipated conflict the webinar will need to be postponed to a later date. We will keep everyone informed of further developments."

Thanks bidnolid!

What I don't understand is if there are real world studies still taking place to confirm the tests accuracy such as the moffit trial and the proposed trial for this grant application.

How can a commercial launch be imminent? Am I missing something?

Obviously before anybody chirps in, I understand this is all dependent on a successful launch across multiple markets, US, UK, EU, CHINA, etc

Curious to know what everyone's exit price is, if you have one. I imagine some people are planning to hold until there's a buyout (if that ever happens).

Personally, I'm hoping the share price reaches 50p within the next five years. Depending on how things are looking at the time, I might hold out for £1.

That said, if a takeover starts to look likely, I may sell a chunk of my holdings and leave the rest in to see how things play out.

Still keeping eye on buying opportunities ( around 1.45p)

We all know that, wasn't expecting anything blockbuster but usually at AGMs investors will speak to management and from conversations and questions some beneficial info can be gathered.

Did anybody here attend? Any insights would be greatly appreciated?

Where are you in the process? Is it available today or if not, when might we see it on the market?

Mr. Behnke: It is not available today but is coming soon to U.S. clinical settings. Healthcare providers will be able to order the test through a portal on our website, and test samples will be processed and analyzed by one of our CLIA-certified and CAP-accredited laboratory partners. We hope those at known risk of lung cancer will be tested, either during their annual physical or a separate visit. They may have a family history of lung cancer, be a previous smoker, or may be concerned about environmental exposures that increase the risk of lung cancer, such as asbestos, radon, or chronic wildfire smoke.

We hope that wide availability and cost effectiveness will encourage people to get tested so that we can significantly move the dial to reduce lung cancer mortality. Five thousand people a day are dying of lung cancer globally. Our mission is to get that number to zero.

What happens in the next 60 days?

Mr. Behnke: We are completing CLIA validation with two additional laboratory partners, and the test will be available to the public soon through healthcare providers. Because a physician’s order is required, providers will be able to request the test either through our website or directly through their office EMR system. Results will be delivered back to clinicians through a secure online portal.

Interesting read

https://www.ceocfointerviews.com/cizzlebio0625.html